Gfs Advisors, LLC Astrazeneca PLC Transaction History

Gfs Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $206,416 - $232,344	-5,600 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $295,460 - $337,620	-8,500 Reduced 60.28%	5,600 $222,000
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $304,148 - $337,911	-9,225 Reduced 39.55%	14,100 $493,000
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $253,511 - $274,762	-7,900 Reduced 25.3%	23,325 $809,000
Q3 2017 Nov 07, 2017	SELL	$28.96 - $34.0 $301,415 - $353,872	-10,408 Reduced 25.0%	31,225 $1.06 Million
Q2 2017 Aug 07, 2017	BUY	N/A	41,633	41,633 $1.42 Million

1,351

489M

5.88M

4.1M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gfs Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gfs Advisors, LLC with notifications on news.